The Hypoglycaemic Effects of the New Zealand Pine Bark Extract on Sucrose Uptake and Glycaemic Responses in Healthy Adults—A Single-Blind, Randomised, Placebo-Controlled, Crossover Trial
Nutrients · 2025
DOI: 10.3390/nu17142277 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Wen Xin Janice Lim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Riddet Institute, Massey University, Palmerston North 4442, New Zealand. Hauptthemen laut MEDLINE: Plant Extracts, Plant Bark, Blood Glucose, Pinus. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ENZO Nutraceuticals Limited, ENZO Nutraceuticals Limited, Paeroa, New Zealand.
Abstract (Originalsprache)
Background
The New Zealand pine bark has been demonstrated in vitro to inhibit digestive enzymes involved in carbohydrate digestion (alpha-amylase, alpha-glucosidase, and dipeptidyl-peptidase 4 (DPP-4)).
Objective
This study aims to investigate the inhibitory effects of the New Zealand pine bark on sucrose uptake and glycaemic responses in humans.
Methods
A single-blind, randomised, placebo-controlled, crossover trial was carried out involving healthy adults (n = 40 (M: 12, F: 28), 30.1 ± 1.3 years, BMI 23.4 ± 0.5 kg/m2, HbA1c 32.5 ± 0.6 mmol/mol, FBG 4.7 ± 0.1 mmol/L). A control (75 g of sucrose powder only), and two doses of the pine bark extract (50 and 400 mg) were provided on separate occasions, with 75 g of sucrose mixed in 250 mL of water. Blood samples were collected at −10, 0, 15, 30, 45, 60, 90, and 120 min via a finger prick test. A linear mixed model for repeated measures (SPSS v30, IBM) was applied, and data presented as model-adjusted mean ± SEM.
Results
Compared to control (247.5 ± 14.0 mmol/L⋅min), the iAUCglucose was significantly reduced with the 400 mg dose (211.8 ± 13.9 mmol/L⋅min, 14.4% reduction, and p = 0.037), but not with 50 mg dose (220.8 ± 14.2 mmol/L⋅min, 10.8% reduction, and p = 0.184). Compared to control (9.1 ± 0.2 mmol/L), glucose peak value was significantly reduced with the 50 mg dose (8.6 ± 0.2 mmol/L, 5.5% reduction, and p = 0.016) but not with the 400 mg dose (8.7 ± 0.2 mmol/L, 4.4% reduction, and p = 0.093). There were no statistically significant changes in postprandial insulin levels with the pine bark extract compared to control.
Conclusions
The New Zealand pine bark extract attenuated sucrose uptake with improved glycaemic responses, and may therefore be useful as a hypoglycaemic adjunct to the diet.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Riddet Institute, Massey University, Palmerston North 4442, New Zealand.
- School of Health Sciences, Massey University, Wellington 6021, New Zealand.
- School of Health Sciences, Massey University, Auckland 0632, New Zealand.
ORCID-Profile: Wen Xin Janice Lim, Rachel A Page, Cheryl S Gammon
Förderung
- ENZO Nutraceuticals Limited
- ENZO Nutraceuticals Limited, Paeroa, New Zealand
Zitieren
APA
Lim, W. X. J., Page, R. A., Gammon, C. S., & Moughan, P. J. (2025). The Hypoglycaemic Effects of the New Zealand Pine Bark Extract on Sucrose Uptake and Glycaemic Responses in Healthy Adults—A Single-Blind, Randomised, Placebo-Controlled, Crossover Trial. Nutrients. https://doi.org/10.3390/nu17142277
Vancouver
Lim WXJ, Page RA, Gammon CS, Moughan PJ. The Hypoglycaemic Effects of the New Zealand Pine Bark Extract on Sucrose Uptake and Glycaemic Responses in Healthy Adults—A Single-Blind, Randomised, Placebo-Controlled, Crossover Trial. Nutrients. 2025. doi:10.3390/nu17142277
BibTeX
@article{Lim2025,
author = {Lim, Wen Xin Janice and Page, Rachel A and Gammon, Cheryl S and Moughan, Paul J},
title = {The Hypoglycaemic Effects of the New Zealand Pine Bark Extract on Sucrose Uptake and Glycaemic Responses in Healthy Adults—A Single-Blind, Randomised, Placebo-Controlled, Crossover Trial},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17142277}
}
EUVIMED